Sofosbuvir plus Peginterferon plus Ribavirin for 12 Weeks in Genotype 3 HCV Infected Patients and Treatment-Experienced Cirrhotic Patients with Genotype 2 HCV Who Did Not Achieve SVR after 16 or 24 Weeks of Sofosbuvir plus Ribavirin

Volume
64
Pagination
455A - 456A
ISSN
0270-9139
Metadata
Show full item record
Authors
Agarwal, K; Schultz, M; Pianko, S; Bank, L; Collier, J; George, J; Priest, M; Ryder, SD; Burman, BE; Cheent, K; Cramp, M; Forton, DM; Leggett, BA; MacQuillan, GC; Ramji, A; Richardson, P; Ryan, MJ; Stace, N; Zekry, A; Zogg, DL; Barnes, E; Brainard, DM; Massetto, B; Chen, F; McHutchison, JG; Subramanian, M; Yoshida, EM; Foster, GR
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/20679
Collections
Return to top